Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
about
Current and emerging strategies for the prevention of graft-versus-host diseaseTreatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.Clinical use of CCR5 inhibitors in HIV and beyondMyxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsEfficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationProteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Acute graft-versus-host disease: are we close to bringing the bench to the bedside?Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.
P2860
Q27016541-D6F092B4-3746-442A-AE96-6D6674C86A09Q33918485-9410A4DD-3339-46E2-BDC1-017CE7603E62Q35018145-086B094E-3FAA-4711-B572-033671DB5217Q35724025-0DCB6584-0396-47EB-BBFC-2E198669A344Q36286890-7DC66A22-FF25-4DA5-B66A-31D533B7A865Q36861714-14FB479C-2DFC-4F8C-94E4-C53E4D8F90FEQ36891433-50945EB1-52C2-4689-80D6-29592A19C6D9Q36904560-0788DE1C-38B5-4474-B91D-1152F01BB0F9Q37402799-F192BE09-45DA-454B-A731-B0678051D6B8Q37538127-CE8E06CB-D90F-4EA5-9F87-E6BCC80CA49DQ37989141-F4BC9E51-B6DF-40B7-BE70-57933920EA1BQ38057376-A2E01F30-6999-4061-AC82-327D3B34B3E8Q39982138-87D03E83-AD8B-4528-A67E-BE8BAB4A8AFAQ52714530-ECFD4E38-2C00-44B4-82F1-521E0C46E6A8Q53646949-ECC5A6C0-B2AF-491B-8D9D-8C3C36483CDB
P2860
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@ast
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@en
type
label
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@ast
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@en
prefLabel
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@ast
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@en
P2093
P2860
P1476
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
@en
P2093
George E Sale
Jeffrey J Molldrem
John I Balogun
Lisa A Palmer
P2860
P304
P356
10.1016/J.BBMT.2009.12.002
P577
2009-12-16T00:00:00Z